Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis (ADOREXT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05866926 |
|
Recruitment Status :
Terminated
(After the analysis of the main ADORE study it is concluded that there is no clinical benefit for the patients.)
First Posted : May 19, 2023
Last Update Posted : February 28, 2024
|
Sponsor:
Ferrer Internacional S.A.
Information provided by (Responsible Party):
Ferrer Internacional S.A.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 9, 2024 |
| Actual Study Completion Date : | February 22, 2024 |